INJ price prediction – Can Injective’s SEC filing trigger a breakout above $5.20?
Injective (INJ) has recovered above $5, but faces key resistance at $5.20 to break out from its July consolidation range. This price movement follows the project's filing for transfer agent registration with the U.S. SEC, aiming to bring regulated, on-chain record-keeping for tokenized real-world assets and securities. The filing initiates the process and does not imply SEC approval. Injective also published a MiCAR whitepaper to support expansion in the EU, highlighting a broader regulatory push. While the RSI indicates strengthening buying momentum, a decisive move above $5.20 is needed to signal an extended recovery. Failure could see a retest of lower support levels.
ambcrypto07/17 18:10
